Descriptions
___________________________________________________________________
Recurrent or metastatic head and neck cancer - bortezomib ± irinotecan.
___________________________________________________________________
 | ||||
| ||||
Protocol (Sponsor)
____________
0525 (RTOG)
____________
0522 (RTOG)
____________
0413 (RTOG)
____________
0517 (RTOG)
____________
0433 (RTOG)
____________
0126 (RTOG)
____________
0521 (RTOG)
____________
0518 (RTOG)
____________
0534 (RTOG)
____________
0229 (RTOG)
____________
0617 (RTOG)
____________ 0127 (RTOG)
(LICH only)
____________
Protocol (Sponsor)
____________
E1304 (ECOG)
____________
Current and Upcoming Cancer Clinical Trials
Currently Recruiting Patients
Coming Soon
Updated: October 13, 2008
____________________________________________________________________________________________
About us | About clinical trials | About cancer treatments | Staff / contacts | Directions | Useful links | Site map
SUNY Downstate MB-CCOP: Bringing state-of-the-art cancer clinical trials to Brooklyn.
Copyright © 2008. All rights reserved.
Click Below for Details
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
| ||||
Click Below for Details
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
_____________
Currently Recruiting Patients - Radiation Oncology
For more details on any of the following cancer clinical trials, please contact:
Yelena Linchevskaya at 718-270-3895.
Descriptions
___________________________________________________________________
Brain Cancer - A Phase III Trial Comparing Conventional Adjuvant Tempozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma ___________________________________________________________________
Head and Neck Cancer - A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) {Followed by Surgery for Selected Patients} for Stage III and IV Head and Neck Cancer.
___________________________________________________________________
Breast Cancer - A Randiomized Phase III Study Of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) For Women with Stage 0, 1 or II Breast Cancer
___________________________________________________________________
Metastasis to Bone - A Randomized Phase III Trial To Evaluate Radiopharmaceuticals and Zolendronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast and Prostate Cancer.
___________________________________________________________________
Metastasis to Bone - A Phase III International Randomized Trial Of Single Versus Multiple Fractions For Re-Irradiation Of Painful Bone Metastases.
___________________________________________________________________
Prostate Cancer - A Phase III randomized study of high dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer.
___________________________________________________________________
Prostate Cancer - A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCRT/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk Prostate Cancer.
___________________________________________________________________
Prostate Cancer - A Phase III, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Zometa for the Prevention of Osteopporosis and associated fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High–Grade and and /or Locally Advanced Prostate Cancer.
___________________________________________________________________
Prostate Cancer - A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy.
___________________________________________________________________
Non-Small-Cell Lung Cancer - A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and High Dose Radiotherapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-Small Cell Lung Carcinoma.
___________________________________________________________________
Non-Small-Cell Lung Cancer - A Randomized Phase III Comparison Of Standard- Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy With Concurrent And Consolidation Carboplatin/Paclitaxel In Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer.
___________________________________________________________________
Non-Small-Cell Lung Cancer - Phase III Chemoprevention Trial of Selenium Supplementation in Persons With Resected Stage I Non-Small Cell Lung Cancer.
___________________________________________________________________
Protocol (Sponsor)
____________
E1505
(ECOG)
____________
IBCSG2402 (ECOG)
____________
06-025
(MSKCC)
____________
06-001
(MSKCC, Alexion)
____________
E2804
(ECOG)
____________
E2805
(ECOG)
____________
E1A05
(ECOG)
____________
E3404
(ECOG)
____________
FC07-171
____________
FC07-162
____________
Descriptions
___________________________________________________________________
Non-small-cell lung cancer – after surgery - chemotherapy ± bevacizumab.
___________________________________________________________________
Breast cancer - SOFT trial - treatment after surgery for patients who have not had their menopause who have hormone-sensitive cancer.
___________________________________________________________________
Breast cancer – metastatic – Comparing 2 dosing schedules of ABI-007 (Abraxane) each also receiving concurrent Bevacizumab.
___________________________________________________________________
Paroxysmal Nocturnal Hemoglobinuria (PNH) – EXPLORE trial - prevalence of PNH in patients with aplastic anemia, myelodysplastic syndrome and other bone marrow failure disorders.
___________________________________________________________________
Advanced renal cell (kidney) cancer - BeST trial - different combinations of bevacizumab, Temsirolimus, and Sorafenib after surgery..
___________________________________________________________________
Renal cell (kidney) cancer - ASSURE trial - adjuvant targeted therapy after surgery to prevent recurrence
___________________________________________________________________
Multiple myeloma – comparing effectiveness of VRD vs VD after completing steroid treatment.
___________________________________________________________________
Non-Hodgkin's Lymphoma - Bulky Stage II, III or IV diffuse large B-cell NHL. Response-adapted therapy with mid-treatment PET scan determining whether to continue R-CHOP or to switch to R-ICE.
___________________________________________________________________
Facing Forward - Guide to make life easier after cancer treatment for breast, colorectal, prostate or lung cancer.
___________________________________________________________________
The Smoking Cessation Research Study - comparing nicotine patch and the nicotine lozenge.
___________________________________________________________________
